Kura Oncology, Inc.
KURA
$9.22
-$0.52-5.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -73.33M | -81.00M | -74.12M | -66.12M | -57.43M |
| Total Depreciation and Amortization | 355.00K | 403.00K | 164.00K | 224.00K | 241.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.62M | 10.07M | 9.18M | 4.57M | 5.31M |
| Change in Net Operating Assets | -20.50M | 187.80M | -15.86M | 32.55M | -20.05M |
| Cash from Operations | -85.85M | 117.27M | -80.63M | -28.78M | -71.93M |
| Capital Expenditure | -128.00K | -2.32M | -2.57M | -1.46M | -292.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.10M | -62.28M | 96.53M | 60.40M | -101.12M |
| Cash from Investing | -24.23M | -64.60M | 93.97M | 58.94M | -101.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 69.00K | 1.14M | 0.00 | 515.00K | 143.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 69.00K | 1.14M | 0.00 | 515.00K | 143.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -110.02M | 53.81M | 13.34M | 30.68M | -173.19M |